Cargando…

Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes

To study the association and possible predictive role of visfatin, resistin, fetuin-A and chemerin with incident type 2 diabetes (T2DM) among Asian Indians with prediabetes. Their association with insulin resistance, β-cell function, glycaemia and anthropometry were also studied. This is a nested ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Susairaj, Priscilla, Snehalatha, Chamukuttan, Nanditha, Arun, Satheesh, Krishnamoorthy, Raghavan, Arun, Vinitha, Ramachandran, Ramachandran, Ambady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514464/
https://www.ncbi.nlm.nih.gov/pubmed/34645898
http://dx.doi.org/10.1038/s41598-021-99784-x
_version_ 1784583392257376256
author Susairaj, Priscilla
Snehalatha, Chamukuttan
Nanditha, Arun
Satheesh, Krishnamoorthy
Raghavan, Arun
Vinitha, Ramachandran
Ramachandran, Ambady
author_facet Susairaj, Priscilla
Snehalatha, Chamukuttan
Nanditha, Arun
Satheesh, Krishnamoorthy
Raghavan, Arun
Vinitha, Ramachandran
Ramachandran, Ambady
author_sort Susairaj, Priscilla
collection PubMed
description To study the association and possible predictive role of visfatin, resistin, fetuin-A and chemerin with incident type 2 diabetes (T2DM) among Asian Indians with prediabetes. Their association with insulin resistance, β-cell function, glycaemia and anthropometry were also studied. This is a nested case–control study of a large 2-year prospective prevention trial in persons at high risk of developing T2DM. Baseline HbA1c values between 6.0% (42 mmol/mol) and 6.2% (44 mmol/mol) were chosen for this analysis (n = 144). At follow-up, persons with incident T2DM (HbA1c ≥ 6.5%, 48 mmol/mol) were grouped as cases (n = 72) and those reverted to normoglycaemia, (HbA1c < 5.7% (39 mmol/mol) as controls (n = 72). Insulin resistance showed the strongest association with incident T2DM ((Odds Ratio (OR): 23.22 [95%CI 6.36–84.77]; p < 0.0001). Baseline visfatin (OR: 6.56 [95%CI 2.21–19.5]; p < 0.001) and fetuin-A (OR: 1.01 [95%CI (1.01–1.04)]; p < 0.0001) independently contributed to the conversion of prediabetes to T2DM. The contribution was significantly higher when their elevated levels coexisted (OR: 12.63 [95%CI 3.57–44.63]; p < 0.0001). The area under the curve was 0.77 ± SE 0.4 (95%CI 0.69–0.85) and 0.80 ± SE 0.04 (95%CI 0.73–0.88) for visfatin (median 17.7 ng/ml, sensitivity and specificity: 75%, p < 0.0001) and fetuin-A (mean 236.2 µg/ml, sensitivity: 71%, specificity: 75%, p < 0.0001) respectively. Higher baseline visfatin and fetuin-A concentrations are strongly associated with incident T2DM and are predictive of future diabetes.
format Online
Article
Text
id pubmed-8514464
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85144642021-10-14 Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes Susairaj, Priscilla Snehalatha, Chamukuttan Nanditha, Arun Satheesh, Krishnamoorthy Raghavan, Arun Vinitha, Ramachandran Ramachandran, Ambady Sci Rep Article To study the association and possible predictive role of visfatin, resistin, fetuin-A and chemerin with incident type 2 diabetes (T2DM) among Asian Indians with prediabetes. Their association with insulin resistance, β-cell function, glycaemia and anthropometry were also studied. This is a nested case–control study of a large 2-year prospective prevention trial in persons at high risk of developing T2DM. Baseline HbA1c values between 6.0% (42 mmol/mol) and 6.2% (44 mmol/mol) were chosen for this analysis (n = 144). At follow-up, persons with incident T2DM (HbA1c ≥ 6.5%, 48 mmol/mol) were grouped as cases (n = 72) and those reverted to normoglycaemia, (HbA1c < 5.7% (39 mmol/mol) as controls (n = 72). Insulin resistance showed the strongest association with incident T2DM ((Odds Ratio (OR): 23.22 [95%CI 6.36–84.77]; p < 0.0001). Baseline visfatin (OR: 6.56 [95%CI 2.21–19.5]; p < 0.001) and fetuin-A (OR: 1.01 [95%CI (1.01–1.04)]; p < 0.0001) independently contributed to the conversion of prediabetes to T2DM. The contribution was significantly higher when their elevated levels coexisted (OR: 12.63 [95%CI 3.57–44.63]; p < 0.0001). The area under the curve was 0.77 ± SE 0.4 (95%CI 0.69–0.85) and 0.80 ± SE 0.04 (95%CI 0.73–0.88) for visfatin (median 17.7 ng/ml, sensitivity and specificity: 75%, p < 0.0001) and fetuin-A (mean 236.2 µg/ml, sensitivity: 71%, specificity: 75%, p < 0.0001) respectively. Higher baseline visfatin and fetuin-A concentrations are strongly associated with incident T2DM and are predictive of future diabetes. Nature Publishing Group UK 2021-10-13 /pmc/articles/PMC8514464/ /pubmed/34645898 http://dx.doi.org/10.1038/s41598-021-99784-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Susairaj, Priscilla
Snehalatha, Chamukuttan
Nanditha, Arun
Satheesh, Krishnamoorthy
Raghavan, Arun
Vinitha, Ramachandran
Ramachandran, Ambady
Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
title Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
title_full Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
title_fullStr Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
title_full_unstemmed Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
title_short Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
title_sort analysis of an indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514464/
https://www.ncbi.nlm.nih.gov/pubmed/34645898
http://dx.doi.org/10.1038/s41598-021-99784-x
work_keys_str_mv AT susairajpriscilla analysisofanindiandiabetespreventionprogrammeonassociationofadipokinesandahepatokinewithincidentdiabetes
AT snehalathachamukuttan analysisofanindiandiabetespreventionprogrammeonassociationofadipokinesandahepatokinewithincidentdiabetes
AT nandithaarun analysisofanindiandiabetespreventionprogrammeonassociationofadipokinesandahepatokinewithincidentdiabetes
AT satheeshkrishnamoorthy analysisofanindiandiabetespreventionprogrammeonassociationofadipokinesandahepatokinewithincidentdiabetes
AT raghavanarun analysisofanindiandiabetespreventionprogrammeonassociationofadipokinesandahepatokinewithincidentdiabetes
AT vinitharamachandran analysisofanindiandiabetespreventionprogrammeonassociationofadipokinesandahepatokinewithincidentdiabetes
AT ramachandranambady analysisofanindiandiabetespreventionprogrammeonassociationofadipokinesandahepatokinewithincidentdiabetes